The Oncology Institute, Inc. TOI Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s operating income?
- The Oncology Institute, Inc. (TOI) reported operating income of -$6.51M in Q1 2026.
- How has The Oncology Institute, Inc.'s operating income changed year-over-year?
- The Oncology Institute, Inc.'s operating income increased by 34.3% year-over-year, from -$9.91M to -$6.51M.
- What is the long-term trend for The Oncology Institute, Inc.'s operating income?
- Over 4 years (2021 to 2025), The Oncology Institute, Inc.'s operating income has grown at a -5.8% compound annual growth rate (CAGR), from -$45.86M to -$36.08M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.